Mono-Therapy Will Double Elan
Forbes - 2 hours, 39 minutes ago
Marketocracy's stock pickers think Elan's multiple schlerosis drug, Tysabri, will succeed despite setbacks.

UBS unveils China brokerage move
CNN.com - 2 hours, 6 minutes ago
Swiss-based financial group UBS AG unveiled plans to take control of Beijing Securities on Wednesday in a move that would make it the first foreign institution to buy into a Chinese brokerage.